Drug Patents owned by Avid Radiopharms Inc
1. Drug name - AMYVID
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8506929 | AVID RADIOPHARMS INC | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
Apr, 2027
(4 years from now) | |
| US7687052 | AVID RADIOPHARMS INC | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
Apr, 2027
(4 years from now) | |
| CN101522624A | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Mar, 2027
(4 years from now) | |
| CN101522624B | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Mar, 2027
(4 years from now) | |
| IN288160B | AVID RADIOPHARMS INC | Styrylpyridine Compounds |
Mar, 2027
(4 years from now) | |
| IN200807219P1 | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Mar, 2027
(4 years from now) | |
| EP2363392B1 | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Mar, 2027
(4 years from now) | |
| EP2363392A1 | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Mar, 2027
(4 years from now) | |
| EP1999109A2 | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Jan, 2028
(5 years from now) | |
| EP1999109B1 | AVID RADIOPHARMS INC | Styrylpyridine Derivatives And Their Use For Binding And Imaging Amyloid Plaques |
Jan, 2028
(5 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 10ML (13.5-51mCi/ML) | SOLUTION;INTRAVENOUS | Discontinued |
| 10-30ML (13.5-51mCi/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 10-50ML (13.5-51mCi/ML) | SOLUTION;INTRAVENOUS | Prescription |
2. Drug name - TAUVID
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8932557 | AVID RADIOPHARMS INC | Imaging agents for detecting neurological dysfunction |
May, 2029
(6 years from now) | |
| CN104781234A | AVID RADIOPHARMS INC | Imaging Agent For Nerve Function Obstacle Detection Based On Carboline And Carbazole |
Aug, 2018
(4 years ago) | |
| CN107011342A | AVID RADIOPHARMS INC | For Tetrahydro-Beta-Carboline-Based Detection Of Neurological Dysfunction And Imaging Agent Carbazole |
Jun, 2019
(3 years ago) | |
| EP2247558A1 | AVID RADIOPHARMS INC | Novel Imaging Agents For Detecting Neurological Dysfunction |
Feb, 2029
(6 years from now) | |
| EP2247558B1 | AVID RADIOPHARMS INC | Novel Imaging Agents For Detecting Neurological Dysfunction |
Feb, 2029
(6 years from now) | |
| EP2852572B1 | AVID RADIOPHARMS INC | Carboline And Carbazole Based Imaging Agents For Detecting Neurological Dysfunction |
Oct, 2032
(10 years from now) | |
| EP2852572A1 | AVID RADIOPHARMS INC | Carboline And Carbazole Based Imaging Agents For Detecting Neurological Dysfunction |
Oct, 2032
(10 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 30ML (8.1-51mCi/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 50ML (8.1-51mCi/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.